Aligos Therapeutics Price Chart
Aligos Therapeutics Volume Chart
Aligos Therapeutics Market Segments
After Hours
+0.00(+0.00%)
| Open | $6.89 |
|---|---|
| Close | $6.89 |
| Low | $6.89 |
| Low Change | 0.00 (0.00%) |
| High | $6.89 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 1.854K |
| Dollar Volume | $12.77K |
Regular Trading Hours
+0.07(+1.03%)
| Open | $6.77 |
|---|---|
| Close | $6.84 |
| Low | $6.58 |
| Low Change | -0.19 (-2.81%) |
| High | $6.97 |
| High Change | +0.20 (+2.95%) |
| Range | $0.39 |
| Volume | 56.415K |
| Dollar Volume | $385.88K |
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $6.89 |
|---|---|
| Close | $6.89 |
| Low | $6.89 |
| Low Change | 0.00 (0.00%) |
| High | $6.89 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 1.854K |
| Dollar Volume | $12.77K |
Regular Trading Hours Yesterday
+0.07(+1.03%)
| Open | $6.77 |
|---|---|
| Close | $6.84 |
| Low | $6.58 |
| Low Change | -0.19 (-2.81%) |
| High | $6.97 |
| High Change | +0.20 (+2.95%) |
| Range | $0.39 |
| Volume | 56.415K |
| Dollar Volume | $385.88K |
Premarket Yesterday
*No Trades in Segment
Aligos Therapeutics News
1 month agoinvesting.comWhy is Aligos Therapeutics stock surging today?
- 1 month agoinvesting.com
Aligos Therapeutics stock jumps on $25M China licensing deal
- 4 months agoinvesting.com
Aligos Therapeutics stock surges on China licensing deal
- 7 months agoinvesting.com
Aligos Therapeutics stock rises on Phase 2 HBV study progress
Aligos Therapeutics Top Trades
Aligos Therapeutics's top trade so far today returned +4.71%, while the top short trade returned -2.81%.
Aligos Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $6.85 |
|---|---|
| 10 Day Moving Average (SMA10) | $5.81 |
| 20 Day Moving Average (SMA20) | $5.26 |
| 50 Day Moving Average (SMA50) | $5.47 |
| 100 Day Moving Average (SMA100) | $6.04 |
| 200 Day Moving Average (SMA200) | $7.21 |
Aligos Therapeutics Statistics
| Average Volume (30 Days) | 277.46K |
|---|---|
| P/E Ratio (Current) | -.48 |
| EPS (Current) | -$14.46 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$85.19M |
| Cash Ratio | 1.29 |
| Current Ratio | 2.56 |
| Quick Ratio | 2.56 |
| Debt to Equity | 0.00 |
| Enterprise Value | $13.81M |
| EV to EBITDA | -0.15 |
| EV to Sales | 2.94 |
| Price to Book | 1.38 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 9.29 |
| Return on Assets | -1.40% |
| Return on Equity | -2.84% |
Aligos Therapeutics Stock Splits
There has been 1 stock split for Aligos Therapeutics (ALGS). The reverse stock split occured on August 19, 2024 and reduced the outstanding shares at a ratio of 25:1.
| Date | Type | Ratio |
|---|---|---|
| Aug 19, 2024 | Reverse | 25:1 |
Aligos Therapeutics Dividends
There have been no dividends for Aligos Therapeutics (ALGS).